Pieris Pharmaceuticals Inc
NASDAQ:PVLA
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Pieris Pharmaceuticals Inc
NASDAQ:PVLA
|
US |
|
Rusolovo PAO
MOEX:ROLO
|
RU |
|
Imuraya Group Co Ltd
TSE:2209
|
JP |
|
E
|
Enagas SA
XMUN:EG4
|
ES |
|
S
|
SSE PLC
DUS:SCT
|
UK |
|
Apex Critical Metals Corp
F:KL9
|
CA |
|
N
|
Nabors Industries Ltd
F:NBI1
|
BM |
|
Phathom Pharmaceuticals Inc
NASDAQ:PHAT
|
US |
Intrinsic Value
There is not enough data to reliably calculate the intrinsic value for Pieris Pharmaceuticals Inc.
Do our valuations actually work? See backtest results .
Fundamental Analysis
What Pieris Pharmaceuticals Does
Pieris Pharmaceuticals is a biotechnology company that develops protein-based medicines using its Anticalin platform, a way to design small, stable proteins that can bind to disease targets. The company’s main work is to create drug candidates for serious illnesses, especially in areas like cancer and respiratory disease, and then advance them through testing.
- Headquarters
- United States of America US
- Employees
- 124
- IPO date
- Dec 18, 2014